|
|
|
Volumn , Issue , 2010, Pages 317-322
|
|
Using HLA antibody detection, monitoring, and treatment to improve long-term allograft survival.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLOANTIBODY;
HLA ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
BLOOD;
DONOR;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY;
HISTOCOMPATIBILITY TEST;
HUMAN;
IMMUNOLOGICAL MONITORING;
IMMUNOLOGY;
MORTALITY;
ORGAN TRANSPLANTATION;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SURVIVAL RATE;
TIME;
TRANSPLANTATION TOLERANCE;
TREATMENT OUTCOME;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY;
HISTOCOMPATIBILITY TESTING;
HLA ANTIGENS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIBODIES;
MONITORING, IMMUNOLOGIC;
ORGAN TRANSPLANTATION;
RISK ASSESSMENT;
RISK FACTORS;
SURVIVAL RATE;
TIME FACTORS;
TISSUE DONORS;
TRANSPLANTATION TOLERANCE;
TREATMENT OUTCOME;
|
|
EID: 79960052369
PISSN: 08909016
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
